![]() |
Name |
3-Isopropoxy-1,1,1,7,7,7-hexamethyl-3,5,5-tris(trimethylsiloxy)tetrasiloxane
|
Molecular Formula | C18H52O7Si7 | |
IUPAC Name* |
propan-2-yl bis(trimethylsilyl) tris(trimethylsilyloxy)silyl silicate
|
|
SMILES |
CC(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)O[Si](C)(C)C
|
|
InChI |
InChI=1S/C18H52O7Si7/c1-18(2)19-31(20-26(3,4)5,21-27(6,7)8)25-32(22-28(9,10)11,23-29(12,13)14)24-30(15,16)17/h18H,1-17H3
|
|
InChIKey |
MODCFEJKGWZWCR-UHFFFAOYSA-N
|
|
Synonyms |
3-Isopropoxy-1,1,1,7,7,7-hexamethyl-3,5,5-tris(trimethylsiloxy)tetrasiloxane; propan-2-yl bis(trimethylsilyl) tris(trimethylsilyloxy)silyl silicate; CHEBI:144334; 3-Isopropoxy-1,1,1,7,7,7-hexamethyl-3,5,5-tris[(trimethylsilyl)oxy]heptanetetrasiloxane; 1-Isopropoxy-3,3,3-trimethyl-1-[(trimethylsilyl)oxy]disiloxanyl tris(trimethylsilyl) orthosilicate #; 71579-69-6
|
|
CAS | NA | |
PubChem CID | 553025 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 577.2 | ALogp: | 6.6 |
HBD: | 0 | HBA: | 7 |
Rotatable Bonds: | 14 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 64.6 | Aromatic Rings: | 0 |
Heavy Atoms: | 32 | QED Weighted: | 0.218 |
Caco-2 Permeability: | -6.292 | MDCK Permeability: | 0.00026016 |
Pgp-inhibitor: | 0.004 | Pgp-substrate: | 0.082 |
Human Intestinal Absorption (HIA): | 0.925 | 20% Bioavailability (F20%): | 0.84 |
30% Bioavailability (F30%): | 0.009 |
Blood-Brain-Barrier Penetration (BBB): | 0 | Plasma Protein Binding (PPB): | 105.70% |
Volume Distribution (VD): | 4.187 | Fu: | 116.65% |
CYP1A2-inhibitor: | 0.339 | CYP1A2-substrate: | 0.971 |
CYP2C19-inhibitor: | 0.829 | CYP2C19-substrate: | 0.972 |
CYP2C9-inhibitor: | 0.806 | CYP2C9-substrate: | 0.94 |
CYP2D6-inhibitor: | 0.022 | CYP2D6-substrate: | 0.899 |
CYP3A4-inhibitor: | 0.265 | CYP3A4-substrate: | 0.088 |
Clearance (CL): | 4.068 | Half-life (T1/2): | 0.227 |
hERG Blockers: | 0.427 | Human Hepatotoxicity (H-HT): | 0.001 |
Drug-inuced Liver Injury (DILI): | 0.008 | AMES Toxicity: | 0.021 |
Rat Oral Acute Toxicity: | 0 | Maximum Recommended Daily Dose: | 0.526 |
Skin Sensitization: | 0.955 | Carcinogencity: | 0.079 |
Eye Corrosion: | 1 | Eye Irritation: | 0.995 |
Respiratory Toxicity: | 0.197 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000530 | ![]() |
0.646 | D0B2OT | ![]() |
0.104 | ||
ENC000373 | ![]() |
0.563 | D06IGU | ![]() |
0.095 | ||
ENC001783 | ![]() |
0.418 | D0Z1ZM | ![]() |
0.091 | ||
ENC001784 | ![]() |
0.364 | D0H2DQ | ![]() |
0.091 | ||
ENC001785 | ![]() |
0.308 | D0R0FE | ![]() |
0.090 | ||
ENC001182 | ![]() |
0.274 | D0R3FP | ![]() |
0.089 | ||
ENC001404 | ![]() |
0.267 | D06ZUP | ![]() |
0.088 | ||
ENC001122 | ![]() |
0.255 | D0X1WJ | ![]() |
0.088 | ||
ENC001123 | ![]() |
0.243 | D0L5FY | ![]() |
0.087 | ||
ENC001149 | ![]() |
0.243 | D03HJK | ![]() |
0.086 |